(Q38042875)

English

KRAS p.G13D mutation and codon 12 mutations are not created equal in predicting clinical outcomes of cetuximab in metastatic colorectal cancer: a systematic review and meta-analysis

scientific article published on 12 September 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 August 2017

0 references

KRAS p.G13D mutation and codon 12 mutations are not created equal in predicting clinical outcomes of cetuximab in metastatic colorectal cancer: a systematic review and meta-analysis (English)

1 reference

Europe PubMed Central

27 August 2017

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

metastatic colon cancer

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Chen Mao

1

1 reference

Europe PubMed Central

27 August 2017

Ya-Fang Huang

2

1 reference

Europe PubMed Central

27 August 2017

Zu-Yao Yang

3

1 reference

Europe PubMed Central

27 August 2017

Da-Yong Zheng

4

1 reference

Europe PubMed Central

27 August 2017

Jin-Zhang Chen

5

1 reference

Europe PubMed Central

27 August 2017

Jin-Ling Tang

6

1 reference

Europe PubMed Central

27 August 2017

language of work or name

0 references

publication date

12 September 2012

1 reference

Europe PubMed Central

27 August 2017

1 reference

Europe PubMed Central

27 August 2017

119

1 reference

Europe PubMed Central

27 August 2017

4

1 reference

Europe PubMed Central

27 August 2017

714-721

1 reference

Europe PubMed Central

27 August 2017

KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27804

21 January 2018

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27804

21 January 2018

Systemic therapy for colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27804

21 January 2018

Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27804

21 January 2018

Cetuximab for the treatment of colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27804

21 January 2018

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27804

21 January 2018

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27804

21 January 2018

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27804

21 January 2018

The importance of KRAS mutations and EGF61A>G polymorphism to the effect of cetuximab and irinotecan in metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27804

21 January 2018

Systemic therapy for colorectal cancer: focus on newer chemotherapy and novel agents

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27804

21 January 2018

Prediction of the response of colorectal cancer to systemic therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27804

21 January 2018

Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27804

21 January 2018

PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27804

21 January 2018

Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27804

21 January 2018

Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27804

21 January 2018

A polymorphism of EGFR extracellular domain is associated with progression free-survival in metastatic colorectal cancer patients receiving cetuximab-based treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27804

21 January 2018

Additional value of EGFR downstream signaling phosphoprotein expression to KRAS status for response to anti-EGFR antibodies in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27804

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27804

21 January 2018

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27804

21 January 2018

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27804

21 January 2018

PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27804

21 January 2018

The Combination of Estimates from Different Experiments

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27804

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.27804

1 reference

Europe PubMed Central

27 August 2017

release_7jwcuts4hnakpmw6v335wiemzm

1 reference

https://api.fatcat.wiki/v0/release/7jwcuts4hnakpmw6v335wiemzm

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

27 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38042875&oldid=1840185832"